Di Zhao, Ph.D.
Areas of Research
- Prostate Cancer Research
- Targeted Therapy Research
Dr. Zhao’s laboratory in the Experimental Radiation Oncology (ERO) department is interested in the functional genomics of prostate cancers with two primary directives: (1) understanding how oncogenic signaling pathways and tumor microenvironment regulate cancer development and metastasis, and (2) searching for biomarkers and context-specific therapeutic targets for personalized cancer medicine.
Zhao D, Cai L, Lu X, Liang X, Li J, Chen P, Ittmann MM, Shang X, Jiang S, Li H, Meng C, Flores I, Song JH, Horner JW, Lan Z, Wu CJ, Li J, Chang Q, Chen KC, Wang G, Deng P, Spring DJ, Wang YA, DePinho RA. Chromatin Regulator, CHD1, Remodels Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer. Cancer Discov. 2020 May 8; CD-19-1352. doi: 10.1158/2159-8290.
Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and Biology of Prostate Cancer. Genes & Dev. 2018 Sep 1;32(17-18):1105-1140
NIH/NCI Pathway to Independence Award (K99/R00)
CPRIT Recruitment of First-Time Tenure-Track Faculty Award
Prostate Cancer Foundation Young Investigator Award
The University of Texas UT System Rising STARs Award
The University of Texas MD Anderson Cancer Center Prostate Cancer SPORE CEP Award